DK162999C - Imidazoquinazolinforbindelse samt fremgangsmaade til fremstilling deraf - Google Patents

Imidazoquinazolinforbindelse samt fremgangsmaade til fremstilling deraf

Info

Publication number
DK162999C
DK162999C DK290084A DK290084A DK162999C DK 162999 C DK162999 C DK 162999C DK 290084 A DK290084 A DK 290084A DK 290084 A DK290084 A DK 290084A DK 162999 C DK162999 C DK 162999C
Authority
DK
Denmark
Prior art keywords
preparing
procedure
compound
imidazoquinazoline
imidazoquinazoline compound
Prior art date
Application number
DK290084A
Other languages
Danish (da)
English (en)
Other versions
DK290084D0 (da
DK162999B (da
DK290084A (da
Inventor
Fumiyoshi Ishikawa
Shinichiro Ashida
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of DK290084D0 publication Critical patent/DK290084D0/da
Publication of DK290084A publication Critical patent/DK290084A/da
Publication of DK162999B publication Critical patent/DK162999B/da
Application granted granted Critical
Publication of DK162999C publication Critical patent/DK162999C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Lubricants (AREA)
  • Furan Compounds (AREA)
DK290084A 1983-06-21 1984-06-13 Imidazoquinazolinforbindelse samt fremgangsmaade til fremstilling deraf DK162999C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58111498A JPS604186A (ja) 1983-06-21 1983-06-21 イミダゾキナゾリン化合物
JP11149883 1983-06-21

Publications (4)

Publication Number Publication Date
DK290084D0 DK290084D0 (da) 1984-06-13
DK290084A DK290084A (da) 1984-12-22
DK162999B DK162999B (da) 1992-01-06
DK162999C true DK162999C (da) 1992-06-01

Family

ID=14562811

Family Applications (1)

Application Number Title Priority Date Filing Date
DK290084A DK162999C (da) 1983-06-21 1984-06-13 Imidazoquinazolinforbindelse samt fremgangsmaade til fremstilling deraf

Country Status (19)

Country Link
US (1) US4596806A (ja)
EP (1) EP0129258B1 (ja)
JP (1) JPS604186A (ja)
KR (1) KR910003153B1 (ja)
AT (1) ATE29884T1 (ja)
AU (1) AU558124B2 (ja)
CA (1) CA1231946A (ja)
DE (1) DE3466392D1 (ja)
DK (1) DK162999C (ja)
ES (1) ES8603483A1 (ja)
FI (1) FI77864C (ja)
GR (1) GR81629B (ja)
IE (1) IE57736B1 (ja)
IL (1) IL72188A (ja)
NO (1) NO161220C (ja)
PH (1) PH19413A (ja)
PT (1) PT78775A (ja)
YU (1) YU43576B (ja)
ZA (1) ZA844437B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663320A (en) * 1983-02-16 1987-05-05 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
JPS6028979A (ja) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン類化合物
EP0153152A3 (en) * 1984-02-15 1987-07-15 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo-/2,1-b/quinnazolinyl)-oxyalkylamides, their preparation, compositions containing them and their use in making medicaments
US4783467A (en) * 1985-06-05 1988-11-08 Pfizer Inc. Tetrahydroimidazoquinazolinone inotropic agents
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
US4670434A (en) * 1985-11-14 1987-06-02 Syntex (U.S.A.) Inc. (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
US4766126A (en) * 1986-01-10 1988-08-23 Daiichi Seiyaku Co., Ltd. Process for treatment of nephritis with imidazoquinazolines
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4761416A (en) * 1986-07-25 1988-08-02 Syntex (U.S.A.) Inc. N-N-disubstituted-ω-[2-amino-3-(carbonylmethyl)-3, 4-dihydroquinazolinyl]oxyalkylamides and related compounds
US6818613B2 (en) * 2001-11-07 2004-11-16 Ortho-Mcneil Pharmaceutical, Inc. Aqueous sustained-release formulations of proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
US3983119A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
US3983120A (en) * 1974-11-06 1976-09-28 Bristol-Myers Company Process for the preparation of optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
US4208521A (en) * 1978-07-31 1980-06-17 Bristol-Myers Company Process for the preparation of imidazo[2,1-b]quinazolinones
US4455311A (en) * 1981-08-28 1984-06-19 Hoffmann-La Roche Inc. Imidazoquinazoline derivatives which inhibit the aggregation of blood platelets, inhibit gastric secretion or have activity on the circulatory system

Also Published As

Publication number Publication date
DK290084D0 (da) 1984-06-13
ES533609A0 (es) 1985-12-16
PT78775A (en) 1984-07-01
FI77864B (fi) 1989-01-31
NO161220C (no) 1989-07-19
AU558124B2 (en) 1987-01-22
KR910003153B1 (ko) 1991-05-20
JPS635030B2 (ja) 1988-02-01
NO842502L (no) 1984-12-27
NO161220B (no) 1989-04-10
IE841549L (en) 1984-12-21
KR850000442A (ko) 1985-02-27
PH19413A (en) 1986-04-10
DE3466392D1 (de) 1987-10-29
EP0129258B1 (en) 1987-09-23
FI842532A0 (fi) 1984-06-21
ES8603483A1 (es) 1985-12-16
DK162999B (da) 1992-01-06
ATE29884T1 (de) 1987-10-15
US4596806A (en) 1986-06-24
DK290084A (da) 1984-12-22
IE57736B1 (en) 1993-03-24
JPS604186A (ja) 1985-01-10
FI842532A (fi) 1984-12-22
GR81629B (ja) 1984-12-11
YU43576B (en) 1989-08-31
AU2943284A (en) 1985-01-03
YU107884A (en) 1986-10-31
IL72188A (en) 1987-03-31
FI77864C (fi) 1989-05-10
ZA844437B (en) 1985-01-30
IL72188A0 (en) 1984-10-31
EP0129258A1 (en) 1984-12-27
CA1231946A (en) 1988-01-26

Similar Documents

Publication Publication Date Title
NO852546L (no) Framgangsmaate for framstilling av multilegerings-komponenter.
FI852516L (fi) Anordning foer dosering av tillvaext befraemjande aemnen.
FI844383A0 (fi) Foerfarande foer framstaellning av nya 7-karboximetoxi-furo-(3,4-c)-pyridinderivat.
DK162999C (da) Imidazoquinazolinforbindelse samt fremgangsmaade til fremstilling deraf
NO865183D0 (no) Styresystem for styring av et en- eller tosporet kjoeretoey.
FI854425A0 (fi) Anordning foer uppvaermning av passagerarutrymmen eller liknande, speciellt i bussar.
FI844900L (fi) Foerfarande foer framstaellning av 4,5,6,7-tetrahydrotiazolo/5,4-c/pyridinderivat.
NO863343L (no) Fremgangsmaate for fremstilling av gem-dihalo-1,8-diamino-4-aza-octaner.
NO860273L (no) Fremgangsmaate for fremstilling av 4,4-dialkyl-2-azetidinoner.
NO870828D0 (no) Fremgangsmaate for fremstilling av biskarbamater.
FI873050A (fi) Foerfarande foer framstaellning av 6-amino-1,2-dihydro-1-hydroxi-2-imino-4-piperidinopyrimidin.
FI860911A (fi) Anordning foer reglering av roekgasernas utloppshastighet i en skorsten.
FI880733A0 (fi) Anordning foer uppbaerning av solv- eller rittgarn i en vaevstol.
NO863045D0 (no) Fremgangsmaate for fremstilling av alkyl-2-karboalkoksy-3,4-dialkoksybenzenkarbamater.
NO872646D0 (no) Cytorhodin s-derivater samt fremgangsmaate for fremstilling av disse.
FI890065A0 (fi) Foerfarande foer framstaellning av 5,8,13, 14-tetrahydrobenz/5,6/isoindolo/2,1-b/isokinolin-8,13-dionderivat.
NO861178L (no) Fremgangsmaate for fremstilling av 1,8-nafthyridinoner.
NO864305D0 (no) Fremgangsmaate for fremstilling av 5-nafthyl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
FI880080A (fi) Foerfarande foer framstaellning av 1,2,3,4-tetrahydro-5h-(1)bensopyrano-(3,4-c)pyridin-5-on.
FI880150A0 (fi) Anordning foer toemning av en saedesbehaollare i en skoerdetroeska.
FI863162A (fi) Foerfarande foer framstaellning av trikalciumfosfat.

Legal Events

Date Code Title Description
PBP Patent lapsed